JP2007246516A - 皮膚改善用添加剤及びこれを用いた飲料、化粧クリーム、化粧水並びにローション - Google Patents
皮膚改善用添加剤及びこれを用いた飲料、化粧クリーム、化粧水並びにローション Download PDFInfo
- Publication number
- JP2007246516A JP2007246516A JP2007033029A JP2007033029A JP2007246516A JP 2007246516 A JP2007246516 A JP 2007246516A JP 2007033029 A JP2007033029 A JP 2007033029A JP 2007033029 A JP2007033029 A JP 2007033029A JP 2007246516 A JP2007246516 A JP 2007246516A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- parts
- lotion
- biotin
- additive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000654 additive Substances 0.000 title claims abstract description 41
- 230000000996 additive effect Effects 0.000 title claims abstract description 36
- 239000008278 cosmetic cream Substances 0.000 title claims abstract description 18
- 235000013361 beverage Nutrition 0.000 title claims description 9
- 239000008341 cosmetic lotion Substances 0.000 title description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 64
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 60
- 235000020958 biotin Nutrition 0.000 claims abstract description 32
- 239000011616 biotin Substances 0.000 claims abstract description 32
- 229960002685 biotin Drugs 0.000 claims abstract description 32
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims abstract description 27
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims abstract description 27
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims abstract description 27
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 26
- 239000000052 vinegar Substances 0.000 claims abstract description 26
- 235000021419 vinegar Nutrition 0.000 claims abstract description 26
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 23
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 23
- 239000006210 lotion Substances 0.000 claims abstract description 23
- 239000013505 freshwater Substances 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 10
- 235000019271 petrolatum Nutrition 0.000 claims description 10
- 239000000454 talc Substances 0.000 claims description 9
- 229910052623 talc Inorganic materials 0.000 claims description 9
- 239000003871 white petrolatum Substances 0.000 claims description 8
- 239000003755 preservative agent Substances 0.000 claims description 6
- 239000003883 ointment base Substances 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 241000218691 Cupressaceae Species 0.000 claims 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 239000006071 cream Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000004347 Perilla Nutrition 0.000 description 5
- 244000124853 Perilla frutescens Species 0.000 description 5
- 244000273928 Zingiber officinale Species 0.000 description 5
- 235000006886 Zingiber officinale Nutrition 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 235000008397 ginger Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 244000126002 Ziziphus vulgaris Species 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 241001125048 Sardina Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940067596 butylparaben Drugs 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000019512 sardine Nutrition 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- 240000000691 Houttuynia cordata Species 0.000 description 2
- 235000013719 Houttuynia cordata Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 229940054333 biotin 2 mg Drugs 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 239000009538 yokuinin Substances 0.000 description 2
- LBIBJGZCAVJMOV-UHFFFAOYSA-N 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol pyridine-3-carboxamide hydrochloride Chemical compound Cl.NC(=O)c1cccnc1.Cc1ncc(CO)c(CO)c1O LBIBJGZCAVJMOV-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000020576 Adrenal disease Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 241000190021 Zelkova Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940086708 ascorbic acid 250 mg Drugs 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229940106265 charcoal Drugs 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000000051 modifying effect Effects 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940042943 pyridoxine 2 mg Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【解決手段】この発明は、アスコルビン酸1重量部に対し、塩酸ピリドキシン0.09〜0.8重量部、ビオチン0.003〜0.03重量部及びジュウヤク0.5〜30.0重量部の割合で混合したことを特徴とする皮膚改善用添加剤を、他の成分又は清水に添加することによって目的を達成した。
【選択図】なし
Description
花粉が飛ぶと、突然目がはれ、目がくしゃくしゃすると共に、鼻水が出て止まらなくなった。また鼻詰まりとなり、時々咳も出て痰も出た。集中力がなくなり、書類の整理能力が激減した。
朝90mlの実施例5の黒酢を飲んだ所、目が急に楽になり、30分位で集中力が戻った。鼻も通ったが、鼻声は残った。
鼻水が少なくなり、まぶたははれているけれども、目はしゃきっとして集中力が回復した。
花粉は相変らず飛んでいたが、鼻水が殆んどなくなり、咳も出なくなった。鼻声もなくなり、正常になったので、集中力は発症前まで回復した。
Claims (9)
- アスコルビン酸1重量部に対し、塩酸ピリドキシン0.09〜0.8重量部及びビオチン0.003〜0.03重量部の割合で混合したことを特徴とする皮膚改善用添加剤。
- アスコルビン酸1重量部に対し、塩酸ピリドキシン0.09〜0.8重量部、ビオチン0.003〜0.03重量部及びジュウヤク0.5〜30.0重量部の割合で混合したことを特徴とする皮膚改善用添加剤。
- アスコルビン酸1重量部に対し、塩酸ピリドキシン0.09〜0.8重量部、ビオチン0.003〜0.03重量部及びジュウヤク0.5〜30.0重量部の割合で混合した添加剤に対して、27〜1020重量部の黒酢を混合したことを特徴とする皮膚改善用飲料。
- アスコルビン酸1重量部に対し、塩酸ピリドキシン0.09〜0.8重量部、ビオチン0.003〜0.03重量部及びジュウヤク0.5〜30.0重量部の割合で混合した添加剤に対して、タルク2〜36重量部と、白色ワセリン42〜8重量部の割合を加えたことを特徴とする化粧クリーム。
- アスコルビン酸1重量部に対し、塩酸ピリドキシン0.09〜0.8重量部、ビオチン0.003〜0.03重量部及びジュウヤク0.5〜30.0重量部の割合に混合した添加剤に対して、タルク2〜36重量部と、白色ワセリン42〜8重量部の割合を加えて混合し、前記混合物の全量に対し、0.02〜0.7%(重量)の防腐剤と、0.002〜0.8%(重量)のハーブオイル又は香料を混合したことを特徴とする化粧クリーム。
- 軟膏基材の全量(100重量部)に対し、請求項2記載の皮膚改善用添加剤を2〜15重量部添加することを特徴とした化粧クリーム。
- 請求項2記載の皮膚改善用添加剤1重量部に対し10〜30重量部の清水を加えて均一に混合したことを特徴とする化粧水。
- 請求項7記載の化粧水に5〜30倍の清水を加えて均一に混合したことを特徴とするボディローション。
- 請求項2記載の皮膚改善用添加剤1重量部に対し、5〜25重量部のジュウヤクエキスを加え、前記に含まれるジュウヤク量を0.5〜35重量部としたことを特徴とするローション。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007033029A JP4756223B2 (ja) | 2006-02-15 | 2007-02-14 | 皮膚改善用添加剤及びこれを用いた飲料、化粧クリーム、化粧水並びにローション |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006038007 | 2006-02-15 | ||
JP2006038007 | 2006-02-15 | ||
JP2007033029A JP4756223B2 (ja) | 2006-02-15 | 2007-02-14 | 皮膚改善用添加剤及びこれを用いた飲料、化粧クリーム、化粧水並びにローション |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007246516A true JP2007246516A (ja) | 2007-09-27 |
JP4756223B2 JP4756223B2 (ja) | 2011-08-24 |
Family
ID=38591180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007033029A Expired - Fee Related JP4756223B2 (ja) | 2006-02-15 | 2007-02-14 | 皮膚改善用添加剤及びこれを用いた飲料、化粧クリーム、化粧水並びにローション |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4756223B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010106008A (ja) * | 2008-09-30 | 2010-05-13 | Kyoei Pharmaceutical Industries Ltd | 便秘治療薬およびその製造方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1045615A (ja) * | 1996-07-31 | 1998-02-17 | Ichimaru Pharcos Co Ltd | 植物抽出物含有線維芽細胞増殖促進剤 |
JPH10120583A (ja) * | 1996-10-21 | 1998-05-12 | Noevir Co Ltd | 抗アレルギー剤、ケミカルメディエーター遊離抑制剤及びこれを含有する抗アレルギー性化粧料,医薬品並びに食品 |
CN1356109A (zh) * | 2000-12-08 | 2002-07-03 | 王宗宽 | 一种痤疮软膏及其制备方法 |
JP2004166616A (ja) * | 2002-11-21 | 2004-06-17 | Acerola Foods:Kk | 健康食品 |
JP2004261030A (ja) * | 2003-02-28 | 2004-09-24 | Mitsukan Group Honsha:Kk | 食酢飲料 |
JP2004339142A (ja) * | 2003-05-15 | 2004-12-02 | Kanebo Ltd | 皮膚化粧料 |
CN1634423A (zh) * | 2004-11-11 | 2005-07-06 | 大连鑫赫化妆品有限公司 | 痤疮外用中药制剂及其制备方法 |
JP2005269951A (ja) * | 2004-03-24 | 2005-10-06 | Mitsukan Group Honsha:Kk | 黒酢飲料 |
-
2007
- 2007-02-14 JP JP2007033029A patent/JP4756223B2/ja not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1045615A (ja) * | 1996-07-31 | 1998-02-17 | Ichimaru Pharcos Co Ltd | 植物抽出物含有線維芽細胞増殖促進剤 |
JPH10120583A (ja) * | 1996-10-21 | 1998-05-12 | Noevir Co Ltd | 抗アレルギー剤、ケミカルメディエーター遊離抑制剤及びこれを含有する抗アレルギー性化粧料,医薬品並びに食品 |
CN1356109A (zh) * | 2000-12-08 | 2002-07-03 | 王宗宽 | 一种痤疮软膏及其制备方法 |
JP2004166616A (ja) * | 2002-11-21 | 2004-06-17 | Acerola Foods:Kk | 健康食品 |
JP2004261030A (ja) * | 2003-02-28 | 2004-09-24 | Mitsukan Group Honsha:Kk | 食酢飲料 |
JP2004339142A (ja) * | 2003-05-15 | 2004-12-02 | Kanebo Ltd | 皮膚化粧料 |
JP2005269951A (ja) * | 2004-03-24 | 2005-10-06 | Mitsukan Group Honsha:Kk | 黒酢飲料 |
CN1634423A (zh) * | 2004-11-11 | 2005-07-06 | 大连鑫赫化妆品有限公司 | 痤疮外用中药制剂及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010106008A (ja) * | 2008-09-30 | 2010-05-13 | Kyoei Pharmaceutical Industries Ltd | 便秘治療薬およびその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
JP4756223B2 (ja) | 2011-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1538927B1 (en) | Fruit and/or vegetable derived composition | |
JP4666537B1 (ja) | しわ改善用美容セット並びにこれを使用する美容方法 | |
JP2004250372A (ja) | 皮膚老化防止・改善剤及び/又は肌荒れ防止・改善剤キット | |
CN107049896A (zh) | 石斛多效原液及其制作方法 | |
KR20220156438A (ko) | 피부 탄력 증진 또는 피부 주름 개선용 조성물 | |
CN111405890A (zh) | 包含芍药苷或芍药内酯苷的内因性老化预防或改善用组合物 | |
JP2005015456A (ja) | 湿疹・皮膚炎群の予防治療剤 | |
JP4756223B2 (ja) | 皮膚改善用添加剤及びこれを用いた飲料、化粧クリーム、化粧水並びにローション | |
KR20170100076A (ko) | 국화 숙성물 함유 화장료 조성물 | |
JP2006306804A (ja) | シワ形成抑制剤 | |
KR20120029116A (ko) | 편백나무 잎 발효물을 이용한 아토피 피부염 개선제 조성물 | |
JP2000139406A (ja) | 抗アレルギ―剤及び抗掻痒剤 | |
KR102283527B1 (ko) | 곡류 발효 추출물을 유효성분으로 함유하는 화장료 조성물 | |
JP6832113B2 (ja) | 医薬組成物 | |
JP4247091B2 (ja) | 皮膚老化防止剤 | |
KR102300580B1 (ko) | 뱅쇼 추출물을 포함하는 화장료 조성물 | |
JP2020523291A (ja) | 新規なクエルセチン系化合物を含む美白用組成物 | |
CN113438946B (zh) | 含有十一烷或十一醛作为活性成分的用于预防过敏、缓解特应性皮炎或使皮肤再生的组合物 | |
JP2004035425A (ja) | むくみ改善剤 | |
JP2005263652A (ja) | 皮膚症状改善剤 | |
JP2016050202A (ja) | ラクトビオン酸を含有する抗ストレス用または恒常性維持用組成物 | |
TW202106320A (zh) | 苦丁萃取物的用途 | |
JP2015140325A (ja) | コラゲナーゼ阻害剤、並びにコラゲナーゼ阻害剤を配合した化粧料組成物及び機能性食品 | |
JP7071406B2 (ja) | 新規なクエルセチン系化合物を含む抗炎症組成物 | |
JP2006169192A (ja) | 脂肪分解促進剤、皮膚外用組成物及び飲食品組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100126 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20100205 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20100224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100309 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100428 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100727 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101025 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110125 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110322 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110401 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110513 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4756223 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140610 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140610 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140610 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |